Global Preimplantation Genetic Testing Market Growth Factors, Demand, Trends and Forecast 2019 to 2023
Global Preimplantation Genetic Testing Market Research Report: Information by Procedure (Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening), Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, LA Typing and others), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late-Onset Genetic Disorders, Inherited Genetic Disease and others), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Service (Reagents and Consumables, Instruments, Software and Services) - Global Forecast till 2025
Market Highlights:
It is estimated that the global
preimplantation genetic testing market is expected to register a CAGR of 10.2% during the forecast period of
2019 to 2025, with a market value of USD 375.8 million in 2018.
Preimplantation genetic
testing is the testing at the pre-implantation stage for detection of genetic
defects in embryos or oocytes. Preimplantation genetic testing has occurred
more frequently in recent years in North America and Europe, due to the
advancement in genetic technology.
The decreasing fertility
rates worldwide enhance the acceptance of the preimplantation genetic testing
to avoid further complications of chromosomal abnormalities with advancing
maternal age. This leads to the growth of the preimplantation genetic testing
market during the forecast period. According to the Vital Statistics Rapid
Release, the total fertility rate for the US in 2017 was 1,764.5 births per
1,000 women, and in 2016 it was 1,820.5, which is 3% less, this shows the
reduction in the rate of fertility.
An increasing number of
fertility clinics worldwide, new development technological advancements in the
field of genetic analysis and high threat of chromosomal abnormalities
with advancing maternal age are the other driving factors for global
preimplantation genetic testing market
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/8121
Intended Audience
- Pharmaceutical companies
- Government and private laboratories
- Research and development (R&D) companies
- Research laboratories
- Market research and consulting service
providers
Segmentation
The global preimplantation
genetic testing market is segmented based on procedure, type, application,
technology, product and service, end user, and region.
The global market for
preimplantation genetic testing, by procedure, is segmented into
preimplantation genetic diagnosis (PGD) and preimplantation genetic screening
(PGS). Hundred different genetic conditions can be tested with Preimplantation
Genetic Diagnosis (PGD) which enables the couple to have a baby with no genetic
defect thus the segment is expected to hold the largest market share owing to
rising awareness population and healthcare experts. Preimplantation Genetic
Screening (PGS) segment is also anticipated to grow profitably to increase
healthy pregnancy.
By type, embryo testing segment
is expected to show favorable growth as the threat of chromosomal abnormalities
increases. By product and service, the reagents and consumables segment
anticipated to hold the largest market share as there is continuous declination
infertility of female due to increasing usage of reagents for the diagnosis. By
technology, the next-generation sequencing segment, and comparative genomic
hybridization also expected to hold large share as its cost is reduced and its
capability to detect mosaicism. The market by end user has been segmented into
maternity centers & fertility clinics
hospitals, diagnostic labs
and research laboratories & academic institutes. Based on region, the
global preimplantation genetic testing market is segmented into the Americas,
Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The market has been
divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle
East & Africa. The global preimplantation genetic testing market in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada. The European global
preimplantation genetic testing market has been sub-divided Western Europe and
Eastern Europe. Western Europe has further been classified as Germany, France,
UK, Italy, Spain, and the rest of Western Europe. The global preimplantation
genetic testing market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific. The IPF treatment
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Access Report Details @ https://www.marketresearchfuture.com/reports/preimplantation-genetic-testing-market-8121
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing
factors in the market. The report provides detail information about and
strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Global Market – Competitive
Dashboard
Some of the major players in the global preimplantation genetic testing
market are Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La Roche AG, Illumina,
Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited, PerkinElmer, Inc., Genesis
Genetics Ltd., Quest Diagnostics Incorporated, Thermo FisherScientific, Inc,
Bioarrayn Genetics, Laboratory Corporation of America Holdings, California
Pacific Medical Center and Reproductive Health Science Ltd
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the
Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/8121
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone: +1 646 845 9312
Comments
Post a Comment